Genedx Holdings Corp Stock Buy Hold or Sell Recommendation
| WGSWW Stock | 0.22 0.03 15.79% |
Assuming the 90 days horizon and your complete indifference towards market risk, our recommendation regarding GeneDx Holdings Corp is 'Strong Hold'. A buy or sell recommendation is an automated directive regarding whether to purchase or sell GeneDx Holdings Corp given historical horizon and risk tolerance. When we issue a 'buy' or 'sell' recommendation for GeneDx Holdings Corp, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out GeneDx Holdings Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as GeneDx and provide practical buy, sell, or hold advice based on investors' constraints. GeneDx Holdings Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in housing.
GeneDx |
Execute GeneDx Holdings Buy or Sell Advice
The GeneDx recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on GeneDx Holdings Corp. Macroaxis does not own or have any residual interests in GeneDx Holdings Corp or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute GeneDx Holdings' advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Modest | Details | |
Volatility | Out of control | Details | |
Hype Condition | Under hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Frail | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
GeneDx Holdings Trading Alerts and Improvement Suggestions
| GeneDx Holdings Corp is way too risky over 90 days horizon | |
| GeneDx Holdings Corp has some characteristics of a very speculative penny stock | |
| GeneDx Holdings Corp appears to be risky and price may revert if volatility continues | |
| GeneDx Holdings Corp has high likelihood to experience some financial distress in the next 2 years | |
| The company reported the revenue of 202.57 M. Net Loss for the year was (175.77 M) with profit before overhead, payroll, taxes, and interest of 162.63 M. | |
| GeneDx Holdings generates negative cash flow from operations | |
| GeneDx Holdings Corp has a frail financial position based on the latest SEC disclosures | |
| Latest headline from news.google.com: GeneDx Holdings Shares Surge Amid Mixed Signals - TipRanks |
GeneDx Holdings Returns Distribution Density
The distribution of GeneDx Holdings' historical returns is an attempt to chart the uncertainty of GeneDx Holdings' future price movements. The chart of the probability distribution of GeneDx Holdings daily returns describes the distribution of returns around its average expected value. We use GeneDx Holdings Corp price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of GeneDx Holdings returns is essential to provide solid investment advice for GeneDx Holdings.
| Mean Return | 0.45 | Value At Risk | -14.29 | Potential Upside | 18.75 | Standard Deviation | 10.57 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of GeneDx Holdings historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
GeneDx Holdings Cash Flow Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (9.0M) | (10.6M) | 4.6M | 975K | 1.1M | 1.2M | |
| Investments | (32.0M) | (20.8M) | (141.3M) | (41.7M) | (37.5M) | (39.4M) | |
| Change In Cash | 4.0M | 282.5M | (263.2M) | (37.7M) | (33.9M) | (32.3M) | |
| Free Cash Flow | (125.1M) | (211.2M) | (333.5M) | (185.9M) | (167.3M) | (175.6M) | |
| Depreciation | 11.7M | 21.8M | 59.3M | 35.8M | 41.2M | 29.7M | |
| Other Non Cash Items | 2.4M | 1.6M | 141.5M | (721K) | (829.2K) | (787.7K) | |
| Capital Expenditures | 32.0M | 20.8M | 14.3M | 5.7M | 5.1M | 4.9M | |
| Net Income | (241.3M) | (245.4M) | (549.0M) | (175.8M) | (158.2M) | (166.1M) | |
| End Period Cash Flow | 119.0M | 401.5M | 138.3M | 99.7M | 89.7M | 139.7M |
GeneDx Holdings Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to GeneDx Holdings or Health Care Technology sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that GeneDx Holdings' price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a GeneDx stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.40 | |
β | Beta against Dow Jones | 0.63 | |
σ | Overall volatility | 10.94 | |
Ir | Information ratio | 0.03 |
GeneDx Holdings Volatility Alert
GeneDx Holdings Corp is showing large volatility of returns over the selected time horizon. GeneDx Holdings Corp is a potential penny stock. Although GeneDx Holdings may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in GeneDx Holdings Corp. We encourage investors to look for signals such as email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on GeneDx instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.GeneDx Holdings Fundamentals Vs Peers
Comparing GeneDx Holdings' fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze GeneDx Holdings' direct or indirect competition across all of the common fundamentals between GeneDx Holdings and the related equities. This way, we can detect undervalued stocks with similar characteristics as GeneDx Holdings or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of GeneDx Holdings' fundamental indicators could also be used in its relative valuation, which is a method of valuing GeneDx Holdings by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare GeneDx Holdings to competition |
| Fundamentals | GeneDx Holdings | Peer Average |
| Return On Equity | -0.36 | -0.31 |
| Return On Asset | -0.0827 | -0.14 |
| Profit Margin | (0.31) % | (1.27) % |
| Operating Margin | (0.10) % | (5.51) % |
| Number Of Shares Shorted | 7.75 K | 4.71 M |
| Revenue | 202.57 M | 9.43 B |
| Gross Profit | 162.63 M | 27.38 B |
| EBITDA | (136.46 M) | 3.9 B |
| Net Income | (175.77 M) | 570.98 M |
| Total Debt | 119.77 M | 5.32 B |
| Book Value Per Share | 7.45 X | 1.93 K |
| Cash Flow From Operations | (180.15 M) | 971.22 M |
| Number Of Employees | 1 K | 18.84 K |
| Beta | 2.18 | -0.15 |
| Total Asset | 473.67 M | 29.47 B |
| Retained Earnings | (1.3 B) | 9.33 B |
| Working Capital | 123.52 M | 1.48 B |
| Net Asset | 473.67 M |
GeneDx Holdings Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as GeneDx . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About GeneDx Holdings Buy or Sell Advice
When is the right time to buy or sell GeneDx Holdings Corp? Buying financial instruments such as GeneDx Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having GeneDx Holdings in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Plastics Thematic Idea Now
Plastics
Companies manufacturing rubber and plastics accessories. The Plastics theme has 47 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Plastics Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for GeneDx Stock Analysis
When running GeneDx Holdings' price analysis, check to measure GeneDx Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy GeneDx Holdings is operating at the current time. Most of GeneDx Holdings' value examination focuses on studying past and present price action to predict the probability of GeneDx Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move GeneDx Holdings' price. Additionally, you may evaluate how the addition of GeneDx Holdings to your portfolios can decrease your overall portfolio volatility.